Close
Digital Health & Ai Innovation summit 2026
APE 2026

Varian Medical Systems, Flatiron Health to Develop Cloud-based Oncology Software

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Konica Minolta and deepc AI Partnership...

Konica Minolta Healthcare Americas and deepc have formed a...

Medtronic Wins FDA Clearance for MiniMed...

Medtronic has received U.S. Food and Drug Administration (FDA)...

Novartis Plans its Fourth US Radioligand...

Novartis, which is a world-leading innovative medicines company, has...

Varian Medical Systems, Inc. and Flatiron Health, inc. said that under a strategic alliance, they will develop the the next generation of cloud-based, electronic health record or EHR, data analytics and decision support software for cancer care providers around the world.
Together, the companies will build upon their existing respective software platforms to deliver a cloud-based integrated medical oncology, radiation oncology and data analytics product suite.
As a first step in the collaboration, both companies will offer customers OncoEMR, Flatiron Health's cloud-based medical oncology EHR. Later this year, OncoEMR will be made seamlessly interoperable with Varian's award-winning ARIA oncology information system, now in use at over 3,800 cancer centers around the world.

Latest stories

Related stories

Konica Minolta and deepc AI Partnership Expands Exa Platform

Konica Minolta Healthcare Americas and deepc have formed a...

Medtronic Wins FDA Clearance for MiniMed Go Smart MDI System

Medtronic has received U.S. Food and Drug Administration (FDA)...

Novartis Plans its Fourth US Radioligand Therapy Facility

Novartis, which is a world-leading innovative medicines company, has...

Tempus-NYU Langone Collaboration Advances Precision Oncology

Tempus and NYU Langone Health have signed a multi-year...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »